Beth Israel Medical Center;

New York, New York 45267

1 studies enrolling now · 178 studies all time

What they study most

AIDS Vacuolar Myelopathy, AIDS-Myelopathy, AIDS-Related Opportunistic Infections, Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, Acute Kidney Injury, Acute Myeloid Leukemia, Adenocarcinoma of the Colon, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Amyotrophic Lateral Sclerosis, Anemia

Studies at this site

• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort — Recruiting now
• Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer — Completed
• Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery — Completed
• RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer — Running, not enrolling
• Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
• Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy — Completed
• Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study — Completed
• Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study — Completed
• A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration — Completed
• S-ICD® System Post Approval Study — Completed
• Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC) — Stopped early
• Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression — Completed
• A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer — Completed
• PDGeneration: Mapping the Future of Parkinson's Disease — Status unconfirmed
• Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis — Stopped early
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed
• Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers — Completed
• rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study — Completed
• Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) — Completed
• Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) — Stopped early
• Prospective Observational Epidemiologic Study of Maraviroc's Safety — Completed
• Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia — Completed
• Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia — Completed
• Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis — Completed
• Vitamin D and Type 2 Diabetes Study — Completed
• A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Stopped early
• A Yoga Program for Breast Cancer Patients Undergoing Chemotherapy — Completed
• Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF) — Completed
• The BEACON Study (Breast Cancer Outcomes With NKTR-102) — Completed
• Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer — Completed
• Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer — Completed
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed
• Standardized Treatment of Pulmonary Exacerbations II — Completed
• A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia — Completed
• Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis — Completed
• Xenform Postmarket Surveillance Study — Completed
• Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches — Completed
• Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer — Completed
• Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer — Completed
• Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases — Completed
• Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer — Completed
• Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme — Completed
• External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer — Completed
• Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy — Completed
• Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) — Completed
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• Post Market Study Using the Xoft Axxent System — Completed